Matthew Sherman

Matthew Sherman

Chief Tech/Sci/R&D Officer at DECIPHERA PHARMACEUTICALS, INC.
70 year
Health Technology
Consumer Services
Health Services

Profile

Matthew L.
Sherman
is currently the Director at Pulmatrix Operating Co., Inc. He is also the Chief Medical Officer & Executive Vice President at Deciphera Pharmaceuticals, Inc. Additionally, he serves as a Member-Alumni Council at Geisel School of Medicine.
Previously, Dr. Sherman held positions as the Director at NewLink Genetics Corp.
from 2018 to 2020.
He was also the Area Director-Therapeutic Oncology at Wyeth Pharmaceuticals LLC in 2013.
From 2016 to 2020, he served as an Independent Director at Pulmatrix, Inc. Dr. Sherman was an Independent Director at Pieris Pharmaceuticals, Inc. from 2018 to 2024.
He was the Head-Clinical Research & Development at Genetics Institute LLC in 2013.
Prior to that, he was the Chief Medical Officer & Executive Vice President at Acceleron Pharma, Inc. from 2015 to 2018.
He also held the position of Chief Medical Officer & Senior Vice President at Synta Pharmaceuticals Corp.
from 2004 to 2006.
Dr. Sherman has an educational background with an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Dartmouth Medical School.

Matthew Sherman active positions

CompaniesPositionStart
DECIPHERA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/10/2019
Director/Board Member -
Corporate Officer/Principal -

Former positions of Matthew Sherman

CompaniesPositionEnd
PIERIS PHARMACEUTICALS Director/Board Member 12/12/2024
LUMOS PHARMA, INC. Director/Board Member 17/03/2020
PULMATRIX, INC. Director/Board Member 30/01/2020
ACCELERON PHARMA INC. Chief Tech/Sci/R&D Officer 04/07/2018
Chief Tech/Sci/R&D Officer 31/12/2005
See the detail of Matthew Sherman's experience

Training of Matthew Sherman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Services

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Matthew Sherman